Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Medicare Drug Benefit: Impact on States, and Cost Containment

Medicare Drug Benefit: Impact on States, and Cost Containment

This presentation outlines key Medicare Modernization Act issues for Medicaid, State Pharmaceutical Assistance Programs, other state agencies, and state employee retiree benefit plans. It also reviews Medicaid cost-containment options being considered in the states related to eligibility, benefits, unit cost, utilization, managed care, revenue enhancement and cost avoidance, and administrative efficiencies.

Blog Post

Bundled Payments: Opportunities and Challenges

As use of bundled payments increases, how do health system stakeholders minimize the risk of unintended consequences and maximize chances this...
Blog Post

ASCO’s Clinical Pathways Recommendations and Remaining Challenges

The American Society of Clinical Oncology (ASCO) today released its “policy statement on clinical pathways in oncology,” which acknowledges the...
Blog Post

#TBT: Value-Based Insurance Design & New Medicare Advantage Model

As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research...
Blog Post

CER Tweets of the Week: Study on Six Potential EBM “Biases”; VBID "Gets Its Medicare Close-up" (August 31-September 4)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared a study examining six potential biases against patients and carers...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Press Release

Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management

Washington, D.C. (December 4, 2014)—A case study published in the December 2014 issue of the Journal of Managed Care & Specialty Pharmacy...
Press Release

Fellowship in Policy Impact of Comparative Effectiveness Research Awarded By National Pharmaceutical Council and George Washington University

[[{"fid":"25703","view_mode":"teaser","type":"media","link_text":null,"attributes":{"height":"360","width":"240","border":"0","alt":"chuck-shih","...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
YouTube Videos

NHC's Boutin: Incorporating Patient Aspirations With Medical Outcomes

Marc Boutin, JD, CEO, National Health Council, says while medical outcomes are critical to patients with chronic illnesses, it's also important for...
YouTube Videos

NHC's Boutin: Measuring Health Outcomes & Patient Aspirations

Marc Boutin, JD, CEO, National Health Council, emphasizes the need to ensure that we are integrating a patient’s perspective at the time that we are...
YouTube Videos

Why are quality measures important? We asked health care thought leaders to tell us why.

Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using to promote system-wide improvement....
YouTube Videos

Shifting the Focus From "How Much" to "How Well" We Spend Our Health Care Dollars

A. Mark Fendrick, MD, director of the Center for Value-Based Insurance design at the University of Michigan, highlights the key findings from a...
Blog Post

Bundled Payments: Opportunities and Challenges

As use of bundled payments increases, how do health system stakeholders minimize the risk of unintended consequences and maximize chances this...
Blog Post

ASCO’s Clinical Pathways Recommendations and Remaining Challenges

The American Society of Clinical Oncology (ASCO) today released its “policy statement on clinical pathways in oncology,” which acknowledges the...
Blog Post

#TBT: Value-Based Insurance Design & New Medicare Advantage Model

As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research...
Blog Post

CER Tweets of the Week: Study on Six Potential EBM “Biases”; VBID "Gets Its Medicare Close-up" (August 31-September 4)

This week on Twitter, comparative effectiveness research (CER) stakeholders shared a study examining six potential biases against patients and carers...

What Contributes Most to High Health Care Costs?

A small segment of the population—often the sickest

Consumer-Directed Health Plans: Pharmacy Benefits & "Better Practices"

On behalf of the National Pharmaceutical Council, Th

  •  
  • 1 of 47
  • >